Puma Biotechnology Statistics
Total Valuation
PBYI has a market cap or net worth of $364.47 million. The enterprise value is $260.76 million.
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBYI has 51.70 million shares outstanding. The number of shares has increased by 4.54% in one year.
| Current Share Class | 51.70M |
| Shares Outstanding | 51.70M |
| Shares Change (YoY) | +4.54% |
| Shares Change (QoQ) | +0.99% |
| Owned by Insiders (%) | 13.79% |
| Owned by Institutions (%) | 70.65% |
| Float | 40.44M |
Valuation Ratios
The trailing PE ratio is 15.51 and the forward PE ratio is 24.96.
| PE Ratio | 15.51 |
| Forward PE | 24.96 |
| PS Ratio | 1.57 |
| Forward PS | 3.23 |
| PB Ratio | 2.49 |
| P/TBV Ratio | 3.24 |
| P/FCF Ratio | 7.91 |
| P/OCF Ratio | 7.92 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.34, with an EV/FCF ratio of 5.66.
| EV / Earnings | 10.94 |
| EV / Sales | 1.12 |
| EV / EBITDA | 7.34 |
| EV / EBIT | 9.98 |
| EV / FCF | 5.66 |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.03 |
| Quick Ratio | 2.72 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.11 |
| Interest Coverage | 12.88 |
Financial Efficiency
Return on equity (ROE) is 18.20% and return on invested capital (ROIC) is 42.29%.
| Return on Equity (ROE) | 18.20% |
| Return on Assets (ROA) | 11.75% |
| Return on Invested Capital (ROIC) | 42.29% |
| Return on Capital Employed (ROCE) | 17.33% |
| Weighted Average Cost of Capital (WACC) | 11.88% |
| Revenue Per Employee | $1.30M |
| Profits Per Employee | $133,128 |
| Employee Count | 179 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 5.84 |
Taxes
In the past 12 months, PBYI has paid $4.27 million in taxes.
| Income Tax | 4.27M |
| Effective Tax Rate | 15.19% |
Stock Price Statistics
The stock price has increased by +44.32% in the last 52 weeks. The beta is 1.33, so PBYI's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | +44.32% |
| 50-Day Moving Average | 9.54 |
| 200-Day Moving Average | 8.04 |
| Relative Strength Index (RSI) | 24.46 |
| Average Volume (20 Days) | 511,519 |
Short Selling Information
The latest short interest is 4.30 million, so 8.31% of the outstanding shares have been sold short.
| Short Interest | 4.30M |
| Short Previous Month | 4.54M |
| Short % of Shares Out | 8.31% |
| Short % of Float | 10.63% |
| Short Ratio (days to cover) | 11.69 |
Income Statement
In the last 12 months, PBYI had revenue of $231.83 million and earned $23.83 million in profits. Earnings per share was $0.45.
| Revenue | 231.83M |
| Gross Profit | 170.60M |
| Operating Income | 26.14M |
| Pretax Income | 28.10M |
| Net Income | 23.83M |
| EBITDA | 35.55M |
| EBIT | 26.14M |
| Earnings Per Share (EPS) | $0.45 |
Full Income Statement Balance Sheet
The company has $108.58 million in cash and $4.87 million in debt, with a net cash position of $103.71 million or $2.01 per share.
| Cash & Cash Equivalents | 108.58M |
| Total Debt | 4.87M |
| Net Cash | 103.71M |
| Net Cash Per Share | $2.01 |
| Equity (Book Value) | 146.61M |
| Book Value Per Share | 2.84 |
| Working Capital | 105.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $46.04 million and capital expenditures $36,000, giving a free cash flow of $46.07 million.
| Operating Cash Flow | 46.04M |
| Capital Expenditures | 36,000 |
| Depreciation & Amortization | 9.41M |
| Net Borrowing | -33.34M |
| Free Cash Flow | 46.07M |
| FCF Per Share | $0.89 |
Full Cash Flow Statement Margins
Gross margin is 73.59%, with operating and profit margins of 11.27% and 10.28%.
| Gross Margin | 73.59% |
| Operating Margin | 11.27% |
| Pretax Margin | 12.12% |
| Profit Margin | 10.28% |
| EBITDA Margin | 15.33% |
| EBIT Margin | 11.27% |
| FCF Margin | 19.87% |
Dividends & Yields
PBYI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.54% |
| Shareholder Yield | -4.54% |
| Earnings Yield | 6.45% |
| FCF Yield | 12.64% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | -1.24% |
| EPS Growth Forecast (3Y) | -26.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PBYI has an Altman Z-Score of -2.81 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.81 |
| Piotroski F-Score | 6 |